nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—CYP2C19—Rosuvastatin—atherosclerosis	0.132	0.195	CbGbCtD
Podofilox—CYP2C19—Simvastatin—atherosclerosis	0.123	0.181	CbGbCtD
Podofilox—CYP2C19—Lovastatin—atherosclerosis	0.12	0.177	CbGbCtD
Podofilox—CYP3A4—Rosuvastatin—atherosclerosis	0.0638	0.0941	CbGbCtD
Podofilox—CYP3A4—Ezetimibe—atherosclerosis	0.0638	0.0941	CbGbCtD
Podofilox—CYP3A4—Simvastatin—atherosclerosis	0.0594	0.0875	CbGbCtD
Podofilox—CYP3A4—Lovastatin—atherosclerosis	0.0581	0.0856	CbGbCtD
Podofilox—CYP3A4—Pravastatin—atherosclerosis	0.0581	0.0856	CbGbCtD
Podofilox—Skin burning sensation—Niacin—atherosclerosis	0.0158	0.1	CcSEcCtD
Podofilox—Redness—Niacin—atherosclerosis	0.00573	0.0362	CcSEcCtD
Podofilox—Tenderness—Lovastatin—atherosclerosis	0.00516	0.0326	CcSEcCtD
Podofilox—Skin ulcer—Niacin—atherosclerosis	0.00497	0.0314	CcSEcCtD
Podofilox—Tenderness—Simvastatin—atherosclerosis	0.00483	0.0305	CcSEcCtD
Podofilox—Tingling sensation—Niacin—atherosclerosis	0.00481	0.0304	CcSEcCtD
Podofilox—Inflammation—Ezetimibe—atherosclerosis	0.00455	0.0288	CcSEcCtD
Podofilox—Tenderness—Pravastatin—atherosclerosis	0.00436	0.0276	CcSEcCtD
Podofilox—Inflammation—Simvastatin—atherosclerosis	0.00434	0.0274	CcSEcCtD
Podofilox—Skin discolouration—Niacin—atherosclerosis	0.00428	0.0271	CcSEcCtD
Podofilox—Skin exfoliation—Niacin—atherosclerosis	0.00369	0.0233	CcSEcCtD
Podofilox—Swelling—Simvastatin—atherosclerosis	0.00347	0.0219	CcSEcCtD
Podofilox—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00327	0.343	CbGdCrCtD
Podofilox—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00313	0.328	CbGdCrCtD
Podofilox—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00313	0.328	CbGdCrCtD
Podofilox—Dermatitis bullous—Niacin—atherosclerosis	0.00294	0.0186	CcSEcCtD
Podofilox—Haematuria—Rosuvastatin—atherosclerosis	0.00283	0.0179	CcSEcCtD
Podofilox—Dry skin—Niacin—atherosclerosis	0.00257	0.0163	CcSEcCtD
Podofilox—Dry skin—Pravastatin—atherosclerosis	0.00253	0.016	CcSEcCtD
Podofilox—Immune system disorder—Ezetimibe—atherosclerosis	0.002	0.0127	CcSEcCtD
Podofilox—Haemoglobin—Niacin—atherosclerosis	0.00195	0.0123	CcSEcCtD
Podofilox—Haemorrhage—Niacin—atherosclerosis	0.00194	0.0123	CcSEcCtD
Podofilox—Erythema—Ezetimibe—atherosclerosis	0.00193	0.0122	CcSEcCtD
Podofilox—Erythema—Simvastatin—atherosclerosis	0.00184	0.0116	CcSEcCtD
Podofilox—Insomnia—Rosuvastatin—atherosclerosis	0.00171	0.0108	CcSEcCtD
Podofilox—Paraesthesia—Rosuvastatin—atherosclerosis	0.0017	0.0108	CcSEcCtD
Podofilox—Erythema—Niacin—atherosclerosis	0.00169	0.0107	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00163	0.0103	CcSEcCtD
Podofilox—Pain—Rosuvastatin—atherosclerosis	0.00162	0.0102	CcSEcCtD
Podofilox—Skin disorder—Ezetimibe—atherosclerosis	0.00153	0.00967	CcSEcCtD
Podofilox—Oedema—Simvastatin—atherosclerosis	0.0015	0.00949	CcSEcCtD
Podofilox—Insomnia—Lovastatin—atherosclerosis	0.00145	0.00918	CcSEcCtD
Podofilox—Paraesthesia—Lovastatin—atherosclerosis	0.00144	0.00912	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00143	0.00903	CcSEcCtD
Podofilox—Insomnia—Ezetimibe—atherosclerosis	0.00143	0.00901	CcSEcCtD
Podofilox—Paraesthesia—Ezetimibe—atherosclerosis	0.00141	0.00894	CcSEcCtD
Podofilox—Oedema—Niacin—atherosclerosis	0.00138	0.00872	CcSEcCtD
Podofilox—Pain—Lovastatin—atherosclerosis	0.00137	0.00868	CcSEcCtD
Podofilox—Insomnia—Simvastatin—atherosclerosis	0.00136	0.00859	CcSEcCtD
Podofilox—Oedema—Pravastatin—atherosclerosis	0.00136	0.00858	CcSEcCtD
Podofilox—Paraesthesia—Simvastatin—atherosclerosis	0.00135	0.00853	CcSEcCtD
Podofilox—Pain—Ezetimibe—atherosclerosis	0.00135	0.00851	CcSEcCtD
Podofilox—Pruritus—Rosuvastatin—atherosclerosis	0.00134	0.00847	CcSEcCtD
Podofilox—Skin disorder—Niacin—atherosclerosis	0.00134	0.00847	CcSEcCtD
Podofilox—Pain—Simvastatin—atherosclerosis	0.00129	0.00812	CcSEcCtD
Podofilox—Dizziness—Rosuvastatin—atherosclerosis	0.00125	0.00792	CcSEcCtD
Podofilox—Insomnia—Niacin—atherosclerosis	0.00125	0.00789	CcSEcCtD
Podofilox—Paraesthesia—Niacin—atherosclerosis	0.00124	0.00783	CcSEcCtD
Podofilox—Insomnia—Pravastatin—atherosclerosis	0.00123	0.00776	CcSEcCtD
Podofilox—Paraesthesia—Pravastatin—atherosclerosis	0.00122	0.00771	CcSEcCtD
Podofilox—Rash—Rosuvastatin—atherosclerosis	0.0012	0.00755	CcSEcCtD
Podofilox—Dermatitis—Rosuvastatin—atherosclerosis	0.00119	0.00755	CcSEcCtD
Podofilox—Headache—Rosuvastatin—atherosclerosis	0.00119	0.0075	CcSEcCtD
Podofilox—Pain—Niacin—atherosclerosis	0.00118	0.00746	CcSEcCtD
Podofilox—Pain—Pravastatin—atherosclerosis	0.00116	0.00734	CcSEcCtD
Podofilox—Pruritus—Lovastatin—atherosclerosis	0.00114	0.00718	CcSEcCtD
Podofilox—Pruritus—Ezetimibe—atherosclerosis	0.00111	0.00704	CcSEcCtD
Podofilox—Pruritus—Simvastatin—atherosclerosis	0.00106	0.00672	CcSEcCtD
Podofilox—Dizziness—Lovastatin—atherosclerosis	0.00106	0.00671	CcSEcCtD
Podofilox—Dizziness—Ezetimibe—atherosclerosis	0.00104	0.00658	CcSEcCtD
Podofilox—Vomiting—Lovastatin—atherosclerosis	0.00102	0.00645	CcSEcCtD
Podofilox—Rash—Lovastatin—atherosclerosis	0.00101	0.0064	CcSEcCtD
Podofilox—Dermatitis—Lovastatin—atherosclerosis	0.00101	0.00639	CcSEcCtD
Podofilox—Headache—Lovastatin—atherosclerosis	0.00101	0.00636	CcSEcCtD
Podofilox—Vomiting—Ezetimibe—atherosclerosis	0.001	0.00633	CcSEcCtD
Podofilox—Dizziness—Simvastatin—atherosclerosis	0.000994	0.00628	CcSEcCtD
Podofilox—Rash—Ezetimibe—atherosclerosis	0.000994	0.00628	CcSEcCtD
Podofilox—Dermatitis—Ezetimibe—atherosclerosis	0.000993	0.00627	CcSEcCtD
Podofilox—Headache—Ezetimibe—atherosclerosis	0.000987	0.00624	CcSEcCtD
Podofilox—Pruritus—Niacin—atherosclerosis	0.000976	0.00617	CcSEcCtD
Podofilox—Pruritus—Pravastatin—atherosclerosis	0.000961	0.00607	CcSEcCtD
Podofilox—Vomiting—Simvastatin—atherosclerosis	0.000955	0.00604	CcSEcCtD
Podofilox—Rash—Simvastatin—atherosclerosis	0.000948	0.00599	CcSEcCtD
Podofilox—Dermatitis—Simvastatin—atherosclerosis	0.000947	0.00598	CcSEcCtD
Podofilox—Headache—Simvastatin—atherosclerosis	0.000941	0.00595	CcSEcCtD
Podofilox—Dizziness—Niacin—atherosclerosis	0.000912	0.00577	CcSEcCtD
Podofilox—Dizziness—Pravastatin—atherosclerosis	0.000898	0.00568	CcSEcCtD
Podofilox—Vomiting—Niacin—atherosclerosis	0.000877	0.00554	CcSEcCtD
Podofilox—Rash—Niacin—atherosclerosis	0.00087	0.0055	CcSEcCtD
Podofilox—Dermatitis—Niacin—atherosclerosis	0.000869	0.00549	CcSEcCtD
Podofilox—Headache—Niacin—atherosclerosis	0.000864	0.00546	CcSEcCtD
Podofilox—Vomiting—Pravastatin—atherosclerosis	0.000864	0.00546	CcSEcCtD
Podofilox—Rash—Pravastatin—atherosclerosis	0.000857	0.00541	CcSEcCtD
Podofilox—Dermatitis—Pravastatin—atherosclerosis	0.000856	0.00541	CcSEcCtD
Podofilox—Headache—Pravastatin—atherosclerosis	0.000851	0.00538	CcSEcCtD
Podofilox—Etoposide—PTGS2—atherosclerosis	0.000672	1	CrCbGaD
Podofilox—TUBA4A—Hemostasis—APOB—atherosclerosis	0.000261	0.0017	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—LEP—atherosclerosis	0.00026	0.0017	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000259	0.00169	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000258	0.00169	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000246	0.00161	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000245	0.0016	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PRKCG—atherosclerosis	0.000242	0.00158	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NOS2—atherosclerosis	0.000242	0.00158	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000238	0.00155	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—PLAUR—atherosclerosis	0.000238	0.00155	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000237	0.00155	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CD36—atherosclerosis	0.000237	0.00154	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000233	0.00152	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—PLG—atherosclerosis	0.000232	0.00152	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—AGT—atherosclerosis	0.00023	0.0015	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.00023	0.0015	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PPARG—atherosclerosis	0.000226	0.00148	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000226	0.00147	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000224	0.00146	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000223	0.00145	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	0.000219	0.00143	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PDGFB—atherosclerosis	0.000218	0.00142	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000217	0.00142	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MMP1—atherosclerosis	0.000216	0.00141	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF2—atherosclerosis	0.000211	0.00138	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CAV1—atherosclerosis	0.000207	0.00135	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	0.000207	0.00135	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—APOA1—atherosclerosis	0.000206	0.00135	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000204	0.00133	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	0.000201	0.00131	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—F2—atherosclerosis	0.000197	0.00129	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000197	0.00128	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS2—atherosclerosis	0.000195	0.00127	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000194	0.00127	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—INS—atherosclerosis	0.000193	0.00126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000192	0.00125	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000191	0.00125	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.00019	0.00124	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CG—atherosclerosis	0.000188	0.00123	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000188	0.00123	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000187	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000186	0.00121	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000185	0.00121	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000184	0.0012	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000183	0.00119	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000181	0.00118	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000177	0.00116	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000176	0.00115	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000173	0.00113	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF1—atherosclerosis	0.000173	0.00113	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP1—atherosclerosis	0.00017	0.00111	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—AGT—atherosclerosis	0.000168	0.00109	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000167	0.00109	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—LEP—atherosclerosis	0.000164	0.00107	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SERPINE1—atherosclerosis	0.000164	0.00107	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ALB—atherosclerosis	0.000164	0.00107	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000163	0.00106	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000161	0.00105	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00016	0.00105	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000158	0.00103	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000157	0.00102	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000157	0.00102	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS3—atherosclerosis	0.000156	0.00102	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—F2—atherosclerosis	0.000155	0.00101	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—MAPK8—atherosclerosis	0.000152	0.000991	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000146	0.000954	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—INS—atherosclerosis	0.00014	0.000916	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.00014	0.00091	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000138	0.000902	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000138	0.000902	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CCL2—atherosclerosis	0.000138	0.000901	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000137	0.000894	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF1—atherosclerosis	0.000136	0.000886	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000134	0.000875	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—atherosclerosis	0.000131	0.000857	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.00013	0.000847	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00013	0.000846	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000125	0.000817	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000124	0.000812	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000124	0.000808	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000122	0.000795	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—atherosclerosis	0.000121	0.000788	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000121	0.000787	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—atherosclerosis	0.000119	0.000777	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000116	0.00076	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000116	0.00076	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000116	0.000757	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000114	0.000746	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000114	0.000741	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—atherosclerosis	0.000113	0.000735	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	0.000113	0.000734	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000112	0.000733	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000112	0.000733	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000112	0.00073	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—atherosclerosis	0.000109	0.000712	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—atherosclerosis	0.000107	0.000696	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000105	0.000687	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000104	0.000681	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000104	0.000677	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—atherosclerosis	0.000103	0.000675	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—atherosclerosis	0.000101	0.000657	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	9.84e-05	0.000642	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	9.84e-05	0.000642	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	9.84e-05	0.000642	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	9.84e-05	0.000642	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	9.72e-05	0.000634	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	9.7e-05	0.000633	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.57e-05	0.000624	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	9.39e-05	0.000612	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.32e-05	0.000608	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	9.03e-05	0.000589	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	9e-05	0.000587	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	8.69e-05	0.000567	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	8.66e-05	0.000565	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	8.56e-05	0.000559	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—atherosclerosis	8.55e-05	0.000558	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—atherosclerosis	8.43e-05	0.00055	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	8.37e-05	0.000546	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLTP—atherosclerosis	8.05e-05	0.000525	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	7.87e-05	0.000514	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	7.46e-05	0.000487	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	7.41e-05	0.000484	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1B—atherosclerosis	7.4e-05	0.000483	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	7.36e-05	0.000481	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	7.28e-05	0.000475	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.26e-05	0.000474	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	7.19e-05	0.000469	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—atherosclerosis	7.19e-05	0.000469	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	7.18e-05	0.000469	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.16e-05	0.000467	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG8—atherosclerosis	6.98e-05	0.000455	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LTA4H—atherosclerosis	6.98e-05	0.000455	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	6.89e-05	0.00045	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.69e-05	0.000437	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PARP1—atherosclerosis	6.6e-05	0.000431	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.51e-05	0.000425	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	6.47e-05	0.000422	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR2—atherosclerosis	6.25e-05	0.000408	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—atherosclerosis	5.98e-05	0.00039	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.8e-05	0.000378	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG1—atherosclerosis	5.52e-05	0.00036	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LCAT—atherosclerosis	5.19e-05	0.000338	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FABP4—atherosclerosis	5.19e-05	0.000338	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.15e-05	0.000336	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA4—atherosclerosis	5.09e-05	0.000332	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SIRT1—atherosclerosis	5.03e-05	0.000328	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP7A1—atherosclerosis	5e-05	0.000326	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLTP—atherosclerosis	4.84e-05	0.000316	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.77e-05	0.000311	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP27A1—atherosclerosis	4.62e-05	0.000302	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.55e-05	0.000297	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.44e-05	0.00029	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA2—atherosclerosis	4.38e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	4.38e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALOX15—atherosclerosis	4.38e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	4.38e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG5—atherosclerosis	4.33e-05	0.000282	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.32e-05	0.000282	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.2e-05	0.000274	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.2e-05	0.000274	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARA—atherosclerosis	4.18e-05	0.000273	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LPA—atherosclerosis	4.18e-05	0.000273	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BGN—atherosclerosis	4.05e-05	0.000264	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.02e-05	0.000262	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA5—atherosclerosis	4.01e-05	0.000262	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.89e-05	0.000254	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	3.86e-05	0.000252	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.81e-05	0.000249	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—atherosclerosis	3.79e-05	0.000247	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.78e-05	0.000247	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.77e-05	0.000246	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALOX5—atherosclerosis	3.73e-05	0.000243	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—atherosclerosis	3.46e-05	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.44e-05	0.000225	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAMPT—atherosclerosis	3.34e-05	0.000218	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.32e-05	0.000217	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LIPC—atherosclerosis	3.32e-05	0.000217	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.32e-05	0.000216	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOC3—atherosclerosis	3.3e-05	0.000215	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LDLR—atherosclerosis	3.28e-05	0.000214	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CETP—atherosclerosis	3.2e-05	0.000209	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FABP4—atherosclerosis	3.12e-05	0.000203	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LCAT—atherosclerosis	3.12e-05	0.000203	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—atherosclerosis	3.11e-05	0.000203	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SCARB1—atherosclerosis	3.07e-05	0.0002	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA4—atherosclerosis	3.06e-05	0.0002	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.01e-05	0.000196	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.99e-05	0.000195	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMGCR—atherosclerosis	2.9e-05	0.000189	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.78e-05	0.000181	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.63e-05	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA2—atherosclerosis	2.63e-05	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.63e-05	0.000172	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.63e-05	0.000172	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.61e-05	0.000171	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.6e-05	0.00017	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCA1—atherosclerosis	2.58e-05	0.000169	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LPA—atherosclerosis	2.51e-05	0.000164	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BGN—atherosclerosis	2.43e-05	0.000159	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA5—atherosclerosis	2.41e-05	0.000157	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.32e-05	0.000151	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.24e-05	0.000146	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—atherosclerosis	2.22e-05	0.000145	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOB—atherosclerosis	2.12e-05	0.000138	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.06e-05	0.000135	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LPL—atherosclerosis	2.03e-05	0.000132	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—atherosclerosis	2.03e-05	0.000132	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.01e-05	0.000131	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LIPC—atherosclerosis	2e-05	0.00013	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOC3—atherosclerosis	1.98e-05	0.00013	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—atherosclerosis	1.98e-05	0.000129	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LDLR—atherosclerosis	1.97e-05	0.000129	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CETP—atherosclerosis	1.93e-05	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CD36—atherosclerosis	1.93e-05	0.000126	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.84e-05	0.00012	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.82e-05	0.000119	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARA—atherosclerosis	1.79e-05	0.000117	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.74e-05	0.000114	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AGT—atherosclerosis	1.73e-05	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—atherosclerosis	1.7e-05	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAV1—atherosclerosis	1.68e-05	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA1—atherosclerosis	1.68e-05	0.00011	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.55e-05	0.000101	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.53e-05	0.0001	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—atherosclerosis	1.48e-05	9.65e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—INS—atherosclerosis	1.45e-05	9.47e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—atherosclerosis	1.37e-05	8.92e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.33e-05	8.69e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—atherosclerosis	1.33e-05	8.68e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOB—atherosclerosis	1.28e-05	8.33e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—atherosclerosis	1.27e-05	8.3e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.24e-05	8.1e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LPL—atherosclerosis	1.22e-05	7.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—atherosclerosis	1.19e-05	7.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.16e-05	7.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CD36—atherosclerosis	1.16e-05	7.56e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.1e-05	7.16e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARA—atherosclerosis	1.08e-05	7.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AGT—atherosclerosis	1.04e-05	6.8e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—atherosclerosis	1.02e-05	6.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAV1—atherosclerosis	1.01e-05	6.6e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA1—atherosclerosis	1.01e-05	6.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.22e-06	6.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—atherosclerosis	8.9e-06	5.81e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—INS—atherosclerosis	8.73e-06	5.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—atherosclerosis	8e-06	5.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—atherosclerosis	7.65e-06	4.99e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—atherosclerosis	7e-06	4.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—atherosclerosis	5.85e-06	3.82e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—atherosclerosis	3.52e-06	2.3e-05	CbGpPWpGaD
